α₁-Antichymotrypsin, Human Plasma

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for at up to 6 months at -20°C.

Please refer to vial label for lot-specific volume prior to lyophilization.

Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Cell permeable: no

Primary Target
Chymotrypsin-like serine proteases

Product does not compete with ATP.

Reversible: no

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Toxicity: Standard Handling (A)

Acute-phase protein present at 45 mg/100 ml in plasma. Specific inhibitor of chymotrypsin-like serine proteinases.

Acute-phase protein present at ~45 mg/100 ml in plasma. Specific inhibitor of chymotrypsin-like serine proteinases. Molecular weight ranges from 65,000-68,000 daltons.

M.W. 65,000-68,000.

Desrochers, P.E., et al. 1992. J. Biol. Chem.267, 5005.
Rayford, A., et al. 1992. J.Neurochem.58, 88.
Travis, J., et al. 1978. Biochemistry17, 5651.

Lyophilized from 150 mM NaCl, 20 mM Tris-HCl, pH 7.4.